Proximagen

Proximagen

Proximagen

Proximagen Group plc (AIM:PRX) is focused on the development and commercialisation of novel therapeutics for diseases of the central nervous system.
Founded
2004
Raised
$16M
Follow us
Alexa global traffic share
Latest funding
$16,000,000
Venture capital - 2011
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Proximagen makes some noise.